rdcapital-net-au9f4ec848

How Much R&D Tax Incentive Funding Can Your Business Access?

Mon, 02 Nov 2026 03:45:12 GMT

How Much R&D Tax Incentive Funding Can Your Business Access?

Developing a new product, improving technology or testing an innovative idea takes more than creativity. It takes money. And for many Australian businesses, the biggest challenge isn't coming up with a promising idea. It's finding enough working capital to keep the project moving.

Australia's Research and Development (R&D) Tax Incentive helps eligible businesses recover some of their research and development costs. But there's a catch: businesses generally need to incur their R&D expenses before they can claim the benefit through their tax return.

That can leave a significant gap between spending money on innovation and receiving the financial support associated with it.

Fortunately, businesses don't always have to wait for their tax refund. R&D tax incentive pre payment loans can provide earlier access to funding based on an anticipated R&D tax benefit.

So, how much funding could your business actually access?

With R&D Capital Partners (R&DCP) , eligible businesses may access between $100,000 and $3 million , based on up to 80% of their projected R&D tax return, subject to lending requirements.

Let's explore how these amounts are calculated, what affects your eligibility and how to determine the funding your business may qualify for.

Understanding the R&D Tax Incentive in Australia

The Australian Government's R&D Tax Incentive encourages businesses to invest in activities that generate new knowledge, develop innovative solutions and advance technology.

Rather than providing an upfront grant, the program generally offers a tax offset based on eligible R&D expenditure.

The amount of the offset depends on factors such as your company's aggregated turnover, corporate tax rate and qualifying expenditure.

Under the current program settings:

Businesses with aggregated turnover below $20 million may qualify for a refundable R&D tax offset equal to their corporate tax rate plus an 18.5% premium.
Businesses with aggregated turnover of $20 million or more may qualify for a non-refundable tax offset calculated using their corporate tax rate and applicable R&D intensity premiums but cannot benefit from R&D Tax prepayment loans as their benefit is delivered as a tax offset not a cash refund.

For smaller businesses, the refundable offset can be particularly valuable because it may result in a cash refund when the relevant tax requirements are satisfied.

However, the timing of that refund can create difficulties.

Imagine a technology company investing heavily in software development throughout the financial year. It needs to pay developers, purchase equipment and cover operational expenses today, but its anticipated R&D refund may not arrive until much later.

That's where R&D prepayment funding can make a difference.

What are R&D Tax Incentive Pre Payment Loans?

R&D Tax Incentive prepayment loans are financing arrangements that allow eligible R&D claimants to borrow against their expected R&D tax refund once eligible R&D activities have been undertaken and expenses incurred as opposed instead of waiting until the following financial when their tax return is prepared, lodged and processed by the ATO.

This additional funding can help cover expenses such as employee salaries, research activities, product development, testing and other business costs.

Unlike equity financing, these loans don't require business owners to sell shares in their company as its non-dilutive capital.

This makes them particularly attractive to startups and growing businesses that want to maintain ownership while improving cash flow.

R&D Capital Partners specialises in this type of funding, using anticipated R&D tax returns as security for its lending arrangements.

Importantly, this is a loan, not an additional government grant. Interest, fees, security requirements and repayment obligations apply.

How Much R&D Tax Incentive Funding Can Your Business Access?

The R&D Tax Incentive funding amount available through R&D Capital Partners depends primarily on your projected tax return and whether your business satisfies its lending criteria.

According to R&DCP's published funding parameters:

Minimum loan amount: $100,000
Maximum loan amount: $3 million
Funding basis: Up to 80% of the projected R&D tax return
Loan structure: Secured funding against the anticipated R&D tax benefit

This means the amount you can potentially borrow increases with the size of your eligible projected refund, up to the lender's maximum limit.

6 Key Factors That Affect Your R&D Tax Incentive Funding Amount

1. Your Eligible R&D Expenditure

The amount your business spends on eligible research and development is one of the biggest factors influencing your potential R&D tax benefit.

Eligible costs may include qualifying employee expenses, contractor costs, materials and other expenditure directly connected with eligible R&D activities.

However, not every expense associated with developing a product automatically qualifies.

For example, routine maintenance, ordinary commercial activities and certain marketing expenses generally don't meet the R&D eligibility requirements.

The stronger and more accurate your eligible expenditure calculation, the more reliable your projected refund will be.

2. Your Company's Annual Turnover

Your company's aggregated turnover affects which R&D tax offset applies.

Businesses below the $20 million turnover threshold may qualify for the refundable offset, while larger businesses generally receive a non-refundable offset.

This distinction matters because prepayment funding relies on the expected tax benefit and its suitability as security.

A business expecting a refundable tax offset may have a different financing position from one receiving a non-refundable offset.

R&DCP will need to assess the nature of the anticipated benefit before determining available funding.

3. The Accuracy of Your Projected Tax Refund

A realistic R&D tax refund estimate is essential.

Lenders need confidence that the projected amount is supported by qualifying expenditure and appropriate documentation.

If your forecast is based on incomplete records or includes potentially ineligible costs, your available funding could be lower than expected.

Businesses should maintain accurate financial records, clearly document R&D activities and work with appropriately qualified tax advisers when preparing their estimates.

A well-supported forecast can also make the funding assessment more straightforward.

4. Your R&D Project's Eligibility

Not every innovative business activity qualifies under the R&D Tax Incentive.

Eligible core R&D activities must generally involve experimental work where the outcome cannot be known or determined in advance and where the purpose is to generate new knowledge.

Supporting R&D activities are also eligible if they are undertaken for the dominant purpose of facilitating the core experimental R&D activities.

R&DCP places particular importance on the eligibility of the R&D activities and associated expenditure supporting a loan application.

If the activities or expenditure cannot be adequately substantiated, the amount available for funding may be affected.

Contemporaneous record keeping using the scientific method is also a key eligibility criteria which involves recording the conduct of your R&D activities and maintaining timesheet to underpin the percentage of annual salaries that can be claimed for R&D staff.

5. Your Business's Financial and Tax Position

Your expected refund is important, but it isn't the only consideration.

R&DCP also conducts lending due diligence and assesses whether applicants satisfy its requirements.

Your company's financial circumstances, existing obligations, ATO position and ability to meet loan commitments may influence approval.

For example, outstanding ATO debts may create eligibility concerns under R&DCP's published criteria.

Businesses should also consider whether they can comfortably meet interest payments while waiting for their tax refund.

6. When You Need the Funding

The stage of your R&D project can influence the funding arrangement available.

Some businesses have already incurred substantial R&D expenditure and are waiting to complete their annual claim.

Others need capital during the financial year to continue their research activities.

R&DCP offers different prepayment structures designed to accommodate these circumstances.

Choosing the appropriate structure can help align funding with your actual cash flow requirements.

R&DCP's Three R&D Prepayment Funding Options

R&D Capital Partners provides three main funding approaches.

Prior-Year R&D Expenditure Funding

This option is designed for eligible businesses that have already incurred R&D expenditure in a previous financial year but haven't yet completed the registration and tax return process.

Rather than waiting until the anticipated refund arrives, businesses may be able to access funding against qualifying prior-year expenditure.

This can be useful when a company wants to reinvest in development immediately after completing a major research phase.

Current-Year R&D Expenditure Funding

For businesses actively undertaking R&D, R&DCP offers funding against current-year expenditure.

Depending on the arrangement, businesses may draw down funding on a quarterly or half-yearly basis.

This approach can help companies manage ongoing development costs instead of relying entirely on existing cash reserves.

For example, a manufacturer developing new production technology may use prepayment funding to support continued testing and development throughout the year.

Longer-Term R&D Project Funding

R&DCP also describes a longer-term funding option linked to a partially funded R&D plan and budget, supported by a positive Advance Finding.

This structure may allow funding at the beginning of a project or financial year, subject to the relevant conditions.

An Advance Finding is a formal decision about the eligibility of specified R&D activities, rather than a guarantee of a tax refund or loan approval.

For businesses planning substantial development projects, this approach may offer additional flexibility.

How Does the R&DCP Funding Process Work?

Understanding the lending process can help you prepare before applying.

R&DCP's published process generally involves the following stages:

Prepare your R&D project plan. Develop a clear outline of your research activities, expected expenditure and project objectives.
Assess R&D eligibility. Ensure the plan is prepared in accordance with the R&D Tax Incentive requirements and undergoes the relevant eligibility review.
Submit your funding application. Provide the information required for R&DCP to assess your proposed loan.
Complete due diligence. R&DCP reviews the application, supporting documentation and lending requirements.
Finalise the loan agreement. Once approved, the secured loan agreement is signed and the applicable establishment fee is paid.
Access approved funding. Drawdowns are made in accordance with the agreed structure and expenditure requirements.
Repay the loan. Interest is paid as agreed, with principal generally repaid from the eventual R&D tax refund or earlier where applicable.

R&DCP states that due diligence is typically completed within 72 hours. Following approval, funds may be available within two days of an eligible drawdown notice.

These are indicative timeframes, not guaranteed approval or settlement periods.

Why Consider R&D Prepayment Funding Instead of Waiting?

Waiting for a tax refund might seem like the simplest option, particularly if your business has sufficient cash reserves.

But for companies operating in competitive industries, delays can be expensive.

A lack of working capital may mean postponing product launches, slowing research, reducing development teams or missing commercial opportunities.

R&D prepayment funding can help businesses:

Maintain momentum on important research projects.
Improve cash flow during development.
Pay employees and suppliers without waiting for a refund.
Reduce the immediate need to raise equity.
Preserve ownership while accessing additional working capital.
Pursue development milestones sooner.

Of course, borrowing has a cost. The value of accessing funding early should be weighed against interest, establishment fees and the company's repayment obligations.

The right decision depends on how effectively the business can use the capital and whether the expected benefits justify the financing costs.

Is Your Business Eligible for R&DCP Funding?

R&D Capital Partners works with Australian businesses undertaking eligible research and development across industries including technology, healthcare, agriculture, manufacturing, education and business services.

Businesses considering an application should be prepared to demonstrate that they have a credible R&D program, supportable expenditure and an anticipated tax benefit suitable for financing.

They must also satisfy R&DCP's lending requirements, including its security arrangements.

R&DCP's published terms describe a secured loan with a first-ranking charge over the company registered on the Personal Property Securities Register (PPSR).

Before applying, review the proposed funding structure with your financial and tax advisers to understand the full costs, risks and obligations.

Frequently Asked Questions

What is the minimum R&D Tax Incentive loan available through R&DCP?

R&D Capital Partners publishes a minimum loan amount of $50,000. The business must still satisfy the applicable lending criteria and have sufficient projected tax benefit to support the loan.

Can my business access 100% of its expected R&D tax refund?

R&DCP's published funding parameters are based on up to 80% of the projected tax return, not 100%. The final approved amount may be lower depending on the assessment.

Is R&D prepayment funding available to startups?

Potentially, yes. Eligible startups undertaking qualifying R&D may be considered, provided they meet the relevant tax incentive and lender requirements.

Do I need to wait until my tax return is lodged?

Not necessarily. R&DCP offers funding structures for eligible prior-year expenditure and current-year expenditure, subject to its approval process.

Will an R&D prepayment loan reduce my ownership?

No shares are issued as part of the loan itself, so it does not directly dilute ownership. However, the business takes on debt and associated security and repayment obligations.

Find Out How Much R&D Funding Your Business Could Access

Your next research breakthrough shouldn't necessarily have to wait until your next tax refund.

If your business is undertaking eligible research and development, understanding your potential R&D Tax Incentive funding amount can help you make more informed decisions about cash flow, project timelines and future investment.

With funding from $50,000 to $3 million , based on up to 80% of the projected R&D tax return, R&D Capital Partners offers eligible Australian businesses a way to access anticipated tax benefits earlier.

Whether you're developing new technology, improving manufacturing processes or investing in scientific research, the right funding arrangement could help you keep moving forward.

Want to explore your funding options?

Contact R&D Capital Partners to discuss your projected R&D tax benefit, understand the lending requirements and find out how much funding your business may be eligible to access.

Disclaimer: This article provides general information only and does not constitute financial, tax or legal advice. R&D Tax Incentive eligibility, refund amounts and loan approvals depend on individual circumstances and applicable requirements. All funding is subject to R&DCP's assessment and loan terms.

R&D Tax Incentive Funding vs Equity Raising: Which Is Right for Your Business?

Tue, 20 Oct 2026 03:51:20 GMT

R&D Tax Incentive Funding vs Equity Raising: Which Is Right for Your Business?

Developing a new product, testing innovative technology or bringing a breakthrough idea to market takes more than expertise and ambition. It takes money. And for many Australian businesses investing in research and development (R&D), finding that money at the right time can be one of the biggest challenges.

You might have a promising project, a capable team and a clear commercial opportunity. But if cash is tied up in ongoing R&D expenses, progress can slow considerably.

Traditionally, businesses looking for growth capital have turned to investors. However, giving away part of your company isn't always the most attractive option, particularly when you're still building its value.

That's where R&D Tax funding in Australia offers an alternative worth considering.

By borrowing against an anticipated R&D Tax Incentive benefit, eligible businesses may be able to access working capital without issuing new shares.

So, how does this approach compare with raising equity? And which option makes more sense for your business?

Let's explore the differences.

Understanding R&D Tax Incentive Funding

The Australian Government's Research and Development Tax Incentive (R&DTI) encourages businesses to invest in innovation by providing tax offsets for eligible R&D expenditure.

Under the current rules, eligible companies with aggregated annual turnover below $20 million may receive a refundable tax offset calculated using their corporate tax rate plus an 18.5% premium. Larger companies generally access a non-refundable offset, subject to the applicable rules.

While this incentive provides valuable financial support, there's a practical challenge: businesses generally need to incur the expenditure before claiming the benefit through the tax system.

That creates a timing gap.

Imagine an Australian technology company spending heavily on software development, engineering staff and product testing. Its anticipated R&D tax refund could be substantial, but the business still needs to pay wages, suppliers and operating expenses in the meantime.

R&D Tax Incentive funding helps address this problem.

Specialist financiers such as R&D Capital Partners (R&DCP) offer funding secured against a company's projected R&D tax benefit.

Instead of waiting until the expected benefit is received, an eligible business can potentially access part of its value earlier.

Importantly, this is a loan, not an additional government grant. The company remains responsible for repayment under the agreed terms.

What Is Equity Raising?

Equity raising works differently.

Rather than borrowing money, a business sells an ownership stake to investors in exchange for capital.

These investors might include angel investors, venture capital firms, private equity groups or strategic industry partners.

For example, if your business is valued at $4 million before an investment and an investor contributes $1 million, that investor would typically own 20% of the company after the transaction, assuming a straightforward share issue.

The immediate attraction is that equity investment generally doesn't require scheduled loan repayments.

However, the trade-off is ownership.

Investors become shareholders, potentially gaining voting rights, information rights, board representation or influence over important business decisions.

Equity raising can be highly effective when a business needs substantial capital to expand. But it may be less appealing when the immediate objective is simply to cover R&D expenses until an expected tax benefit arrives.

R&D Tax Funding vs Equity Raising: Key Differences

Both options can provide much-needed capital, but they solve different financial problems.

Factor

R&D Tax Incentive Funding

Equity Raising

Ownership

No new shares issued

Existing ownership diluted

Repayment

Loan must be repaid

Generally no loan repayment

Funding amount

Linked to eligible anticipated tax benefit

Based on investor appetite and valuation

Cost

Interest and applicable fees

Ownership and future value surrendered

Cash runway

Bridges a funding gap

Can support longer-term growth

Control

Existing shareholders retain ownership

Investors may receive governance rights

Main risk

Debt obligations and tax benefit uncertainty

Dilution and investor expectations

Neither option is automatically better. The right choice depends on what you're funding, how much capital you need and where your business sits in its growth journey.

1. Cash Runway: How Long Can Your Business Keep Operating?

Cash runway is the amount of time your business can continue operating before it needs additional funding.

For R&D-intensive companies, maintaining sufficient runway is essential. Development timelines can change, technical problems can emerge and commercialisation often takes longer than expected.

How R&D Tax funding can extend your runway

Suppose your company has enough cash to operate for another four months, but you anticipate receiving an R&D tax refund later in the year.

Without additional capital, you might need to reduce development spending, delay hiring or put important projects on hold.

Borrowing against your anticipated refund could provide a temporary cash flow bridge, allowing you to continue eligible development activities while waiting for the tax benefit.

R&D Capital Partners specifically identifies extending cash runway as a benefit of its prepayment funding service.

This can be particularly useful when a business expects a future cash inflow but needs funds sooner.

How equity raising affects runway

Equity investment can provide a larger pool of capital, potentially supporting operations over several years.

That makes it attractive for businesses planning significant expansion, recruitment, infrastructure investment or entry into new markets.

However, raising equity can involve investor negotiations, due diligence, valuation discussions and legal documentation.

If your business needs working capital relatively quickly, a lengthy capital-raising process may create additional pressure.

The key question: Are you bridging a temporary funding gap, or financing a much larger growth strategy?

2. Ownership Dilution: How Much of Your Business Are You Willing to Give Up?

For founders, ownership dilution is often one of the most important considerations.

When you raise equity, your percentage ownership typically decreases.

This might seem manageable during an early funding round, but repeated capital raises can significantly reduce a founder's long-term stake.

Consider a simple example.

You currently own 100% of your business. An investor offers $500,000 in exchange for 20% ownership.

You receive the funding, but your stake falls to 80%.

If the company eventually sells for $10 million, that 20% stake could represent $2 million in value, assuming no further ownership changes.

Of course, investor capital might help the business achieve a much higher valuation than it could otherwise reach. Dilution isn't necessarily a bad outcome.

But it is a meaningful financial decision.

The non-dilutive advantage of R&D Tax funding

One of the main attractions of R&D Tax Incentive funding is that it doesn't require issuing additional shares.

R&DCP specifically highlights avoiding equity dilution as a benefit of its lending structure.

This allows founders and existing shareholders to retain their ownership percentages while accessing funding linked to anticipated R&D tax benefits.

For companies that believe their valuation could increase after reaching the next technical or commercial milestone, maintaining ownership can be particularly valuable.

It also gives founders the option to consider equity investment later, potentially from a stronger negotiating position.

3. Comparing the True Cost of Funding

Every funding option has a cost. The important thing is understanding how that cost is calculated.

The cost of R&D Tax Incentive funding

With R&D funding loans, businesses generally pay interest and any applicable establishment or other contractual fees.

The overall cost depends on factors such as the amount borrowed, loan duration, repayment arrangements and agreed pricing.

R&D Capital Partners outlines a funding structure involving an establishment fee, monthly interest payments and repayment from the anticipated tax refund.

Before accepting finance, businesses should understand the total expected cost, security requirements and what happens if their R&D claim is delayed or reduced.

The cost of raising equity

Equity financing typically avoids interest and scheduled principal repayments.

However, it involves giving investors a share of the company's future value.

That cost can be difficult to quantify when the investment is made.

If the company grows significantly, the economic value of the ownership surrendered could exceed the cost of short-term debt financing.

On the other hand, if an investor brings substantial expertise, commercial relationships or strategic opportunities, their contribution may justify the dilution.

The comparison shouldn't simply be interest versus no interest.

It should be the total financial and strategic impact of each funding arrangement.

4. Speed, Flexibility and Funding Certainty

Timing matters when you're managing an R&D project.

A delayed funding decision can mean postponed trials, interrupted product development or missed opportunities.

Specialist R&D funding may provide a more targeted process because the lender focuses on the anticipated tax benefit, eligible expenditure and the company's financial circumstances.

R&D Capital Partners offers funding arrangements linked to prior-year expenditure, current-year expenditure and certain longer-term R&D plans.

Its published service information describes drawdowns linked to eligible expenditure and lender due diligence. Actual funding remains subject to approval and contractual conditions.

Equity raising is less predictable.

You need to identify suitable investors, demonstrate the commercial opportunity, agree on valuation and negotiate investment terms.

For some companies, this process is worthwhile. For others, particularly those seeking a relatively modest cash flow bridge, it can become a distraction from the R&D itself.

Neither funding route is guaranteed, so businesses should plan conservatively rather than assume money will arrive by a particular date.

5. When Does R&D Tax Funding Make More Sense?

R&D Tax Incentive funding can be particularly attractive when your business has a clearly defined R&D program and expects an eligible tax benefit.

It may be worth considering if:

Your business is investing heavily in eligible R&D activities.
You anticipate receiving a refundable R&D tax offset.
You need working capital to maintain development momentum.
You want to avoid diluting existing shareholders.
You expect to reach important milestones before your next capital raise.
You have a realistic plan for repaying the loan.

For example, an Australian medical technology company might need additional funding to complete product testing before its next investment round.

Accessing part of its anticipated R&D refund could help the company reach that milestone without immediately selling more equity.

However, R&D funding is not suitable for every business. Eligibility, expenditure documentation, expected refund amounts and repayment capacity all need careful assessment.

A projected tax benefit is not a guaranteed payment. Claims may be reviewed, adjusted or delayed, and borrowers need to understand their obligations if the anticipated refund is lower than expected.

6. When Is Equity Raising the Better Choice?

Equity investment may be more appropriate when your business needs capital beyond what its anticipated R&D tax benefit can support.

This might include funding for:

Large-scale commercialisation or international expansion.
Acquisitions, major equipment purchases or infrastructure.
Sales and marketing growth.
Long-term operations before the business generates meaningful revenue.
Strategic partnerships requiring specialist investor expertise.

Equity can also make sense when the business cannot comfortably service debt or when future cash inflows are too uncertain to support borrowing.

A strong investor may bring much more than money, including industry connections, mentoring, governance expertise and access to future investment rounds.

For some businesses, these advantages outweigh the dilution.

7. Can You Combine R&D Tax Funding and Equity Raising?

Absolutely. In fact, the two approaches can complement each other.

Consider a growing Australian software company preparing for a Series A investment round.

The founders believe completing an important product milestone will strengthen their valuation. However, they need additional working capital to finish development.

Rather than raising equity immediately, the company might use R&D Tax Incentive funding to support its eligible development expenditure.

Once the milestone is achieved, the business could approach investors with a more developed product and stronger commercial evidence.

This strategy may improve its negotiating position, although a higher valuation is never guaranteed.

Alternatively, a company might use equity investment for long-term expansion while relying on R&D prepayment finance to manage shorter-term cash flow requirements.

The goal is to choose funding sources that match the timing, purpose and risk of each financial need.

How R&D Capital Partners Can Help

At R&D Capital Partners, we understand that innovation doesn't always move at the same pace as the tax system.

Our specialist R&D Tax Incentive prepayment funding service is designed to help eligible Australian businesses access capital secured against anticipated R&D tax benefits.

Rather than issuing new shares, businesses may be able to borrow against their projected refund and retain existing ownership.

Our funding arrangements can support different stages of the R&D cycle, including qualifying prior-year and current-year expenditure.

By focusing on R&D eligibility and the anticipated tax benefit, we aim to provide a practical alternative to traditional funding options.

Explore our R&D Tax Incentive funding services to understand the available structures and application process.

Final Thoughts: Choosing the Right Funding Strategy

There's no universal answer to the question of R&D Tax funding versus equity raising.

If your business needs substantial long-term growth capital and would benefit from strategic investors, equity raising could be the right choice.

But if your immediate challenge is bridging the gap between R&D expenditure and an anticipated tax refund, specialist R&D funding may offer a more suitable solution.

The biggest difference is what you're giving up.

With equity, you're sharing future ownership and potential value. With R&D Tax Incentive funding, you're taking on a repayment obligation and financing costs while retaining your existing equity.

Before deciding, assess your cash runway, projected tax benefit, borrowing costs, repayment capacity and longer-term growth plans.

Looking for R&D Tax funding in Australia without giving away equity?

Contact R&D Capital Partners to discuss your R&D activities, anticipated tax benefit and potential funding options.

Frequently Asked Questions

Is R&D Tax Incentive funding the same as receiving an R&D tax refund?

No. R&D Tax Incentive funding involves borrowing against an anticipated tax benefit. The refund or offset itself is administered through the Australian tax system, while the loan is provided by a financier and must be repaid under its terms.

Does R&D Tax funding dilute company ownership?

A conventional R&D tax prepayment loan does not require issuing new shares, so existing ownership percentages remain unchanged. However, borrowers still incur financing costs and contractual obligations.

Can startups access R&D Tax funding in Australia?

Potentially. Eligible startups conducting qualifying R&D may be able to access specialist funding, depending on their anticipated tax benefit, expenditure records, financial position and lender requirements.

Is R&D Tax funding better than venture capital?

It depends on your needs. R&D funding can help bridge short-term cash flow gaps without equity dilution, while venture capital may provide larger amounts of growth capital and valuable strategic support.

How R&D Tax Incentive Funding Can Extend Your Startup’s Cash Runway

Wed, 07 Oct 2026 06:43:09 GMT

How R&D Tax Incentive Funding Can Extend Your Startup’s Cash Runway

For an early-stage company, cash runway can determine whether a promising idea gets enough time to become a commercial success.

Startups developing new software, medical technology, advanced manufacturing processes, agricultural technology or other innovative products often face the same financial challenge: significant development costs arrive well before meaningful revenue.

Engineers need to be paid. Prototypes need to be built. Software needs to be tested. Experiments need to be run. Yet the business may have relatively few tangible assets that a traditional lender can use as security.

This is where R&D Tax funding for startups in Australia can play an important role.

For companies undertaking eligible research and development, Australia's R&D Tax Incentive (R&DTI) can offset some of the cost of eligible R&D. However, there can be a significant timing gap between spending money on development and receiving the resulting tax benefit.

R&D Tax Incentive prepayment funding can potentially bring some of that expected benefit forward, giving eligible startups additional working capital at a time when cash can have the greatest impact.

Why Cash Runway Matters So Much for R&D-Intensive Startups

Cash runway is essentially the amount of time a company can continue operating before its available cash is exhausted.

For an established companies generating predictable revenue, managing runway may be relatively straightforward. For an R&D-intensive startup, it can be very different.

A technology company might spend months developing and testing a new platform before it has a market-ready product. A biotech business could face lengthy experimental and validation stages. An advanced manufacturing company may need several prototype iterations before it reaches commercial production.

These companies can have valuable intellectual property and substantial growth potential without owning much in the way of property, machinery or other assets that traditional lenders typically prefer as security.

That creates a funding challenge.

The company needs capital to create value, but much of that value may still exist in the future.

How the R&D Tax Incentive Helps

The Australian Government's R&D Tax Incentive is designed to encourage companies to undertake R&D they might not otherwise conduct by offsetting some of the associated costs.

For companies with aggregated turnover below $20 million, the refundable R&D tax offset is currently calculated as the company's corporate tax rate plus an 18.5% premium. Different rules apply to companies with aggregated turnover of $20 million or more.

Eligibility depends on the company, the activities it conducts and the expenditure being claimed.

Core R&D activities generally need to be experimental activities conducted to generate new knowledge, where the outcome cannot be known or determined in advance and can only be determined through a systematic progression of work. Certain directly related supporting activities may also qualify.

For startups genuinely undertaking experimental development, the R&DTI can therefore represent an important part of the overall funding picture.

There is, however, a practical issue: timing .

The Cash Flow Gap Between R&D Spending and the Tax Benefit

Imagine a startup developing a new technology throughout the financial year.

The business pays developers, engineers and other eligible development costs as the work occurs. Cash leaves the bank account today.

The R&D Tax Incentive benefit comes later.

Companies generally need to register eligible activities and lodge the relevant tax return before receiving a refundable tax offset. The R&DTI registration deadline is generally 10 months after the end of the relevant income year.

For a cash-rich company, that delay may simply be part of normal financial planning.

For a startup with a limited runway, those months can matter enormously.

A business could have substantial eligible R&D expenditure and an expected future tax benefit while simultaneously facing a near-term cash shortage.

That is the problem R&D Tax Incentive prepayment funding is designed to address.

What Is R&D Tax Incentive Prepayment Funding?

Rather than waiting until the normal tax process is completed, an eligible company may be able to borrow against its projected R&D Tax Incentive benefit.

R&D Capital Partners provides funding secured against the company's future tax return, subject to its eligibility and lending requirements.

In practical terms, this can transform an expected future benefit into working capital that can be deployed earlier.

R&D Capital Partners offers funding against prior-year expenditure as well as current-year eligible expenditure, with current-year funding potentially drawn on a quarterly or half-yearly basis. Funding can range from $50,000 to $3 million and is based on up to 80% of the projected tax return.

This can be particularly relevant to early-stage businesses because the funding structure focuses on the expected R&D tax benefit rather than relying solely on the type of tangible assets typically required for conventional business finance.

How Additional Runway Can Change a Startup's Position

Extending runway isn't simply about keeping money in the bank for longer. The real value may come from what the business can achieve during that additional time .

Consider a startup that expects to raise its next equity round in six months but needs additional capital to maintain its development program.

Without extra funding, management might have to slow recruitment, postpone experiments, reduce development expenditure or begin raising equity earlier than planned.

An R&D Tax Incentive prepayment facility could potentially provide another option.

With additional runway, the company may be able to continue working towards milestones such as:

completing a prototype or minimum viable product;
achieving an important technical validation;
completing another development phase;
generating meaningful test data;
progressing regulatory or commercial readiness;
demonstrating stronger customer adoption;
reaching a significant product release; or
moving closer to revenue generation.

Those milestones can change the conversation when the company next approaches investors.

Reaching Milestones Before Raising Equity

Timing can be particularly important when raising startup capital.

A company raising money while its product is still at a very early stage may present investors with substantial technical, commercial and execution risk.

Several months later, that same company might have a functioning prototype, successful test results, customers trialling the technology or stronger evidence that its technical approach works.

There is no guarantee that achieving milestones will result in a higher valuation or successful capital raise. However, demonstrating tangible progress can potentially put founders in a stronger position when speaking with prospective investors.

This is one reason extending runway can be strategically valuable.

Rather than raising capital simply because cash is running low, founders may have more flexibility over when they approach the market.

Avoiding Unnecessary Equity Dilution

Equity is an essential source of capital for many startups, but issuing new shares comes with a permanent cost: dilution.

Founders and existing shareholders give up part of their ownership in exchange for capital.

R&D Tax Incentive prepayment funding is debt rather than an equity investment. It therefore does not require the company to issue shares as part of the funding arrangement.

That doesn't mean debt is automatically better than equity. Loans involve fees, interest, security requirements and repayment obligations, so companies need to assess whether borrowing is appropriate for their financial position.

But where a business expects an R&D tax benefit and needs relatively short-term working capital, accessing funding against that future benefit may provide an alternative to undertaking an equity raise purely to bridge a temporary cash flow gap.

Why This Can Suit Asset-Light Startups

Many innovative companies do not fit traditional lending models particularly well.

A software startup's primary assets might be source code, intellectual property and the expertise of its development team. A medtech startup may have valuable research but still be working towards a commercially ready device.

These assets can be extremely valuable to the business without providing conventional lenders with straightforward collateral.

R&D Capital Partners takes a different approach by using the future tax return as collateral for its prepayment funding.

This can make R&D funding particularly relevant for startups in areas including technology, healthcare, biotechnology, AgTech, EdTech and advanced manufacturing where substantial development spending can occur before a company builds a conventional asset base.

Documentation Still Matters

Access to R&D funding starts with having eligible R&D.

The R&D Tax Incentive is a self-assessment program, and companies are responsible for ensuring their entity, activities and expenditure meet the relevant requirements.

Good record keeping is therefore important.

Businesses should maintain evidence of their R&D activities throughout the development process rather than attempting to reconstruct everything at year-end.

For core R&D activities, this means being able to demonstrate matters such as the technical uncertainty being addressed, the new knowledge being sought and the systematic progression of work involving hypothesis, experiment, observation, evaluation and logical conclusions.

This is particularly important for software companies. Developing software does not automatically constitute eligible R&D. Routine activities using established tools or known methods may not qualify as core R&D simply because they involve development work.

Think About R&D Funding as Part of Runway Planning

One of the most useful changes a startup can make is to stop treating the R&D Tax Incentive purely as a year-end tax matter.

If R&D is a significant part of your expenditure, the expected benefit can potentially form part of broader cash flow and funding planning.

A startup might map its expected cash position alongside development expenditure, R&D eligibility, anticipated tax benefits, upcoming milestones and future capital requirements.

This provides management with a clearer picture of potential funding gaps before they become urgent.

The objective isn't simply to borrow more money. It is to match the right form of capital to the right stage of the business.

Long-term expansion may require equity. Equipment might suit asset finance. Other activities may require different facilities.

But when the underlying issue is the timing gap between eligible R&D expenditure and a future tax benefit, R&D Tax Incentive prepayment funding may provide a more targeted solution.

Give Your Innovation More Time to Deliver

For an early-stage business, another few months of runway can be significant.

It can mean another product iteration, another round of experiments, another technical milestone or simply enough time to approach the next capital raise from a more developed position.

For companies investing heavily in innovation but holding limited tangible assets, R&D funding for startups in Australia can therefore be more than a short-term cash flow tool.

Used appropriately, it can help bridge the gap between today's development expenditure and tomorrow's R&D Tax Incentive benefit—allowing the company to keep investing in the work that creates its future value.

R&D Capital Partners specialises in R&D Tax Incentive prepayment funding for Australian businesses undertaking eligible research and development. Funding is available subject to eligibility, due diligence and lending criteria.

Speak with R&D Capital Partners to explore whether R&D Tax Incentive prepayment funding could help extend your startup's cash runway.

R&D Tax Prepayment Loan Agreements: What Australian Businesses Need to Know

Tue, 29 Sep 2026 04:03:10 GMT

R&D Tax Prepayment Loan Agreements: What Australian Businesses Need to Know

For a lot of innovative Australian businesses, research and development is where future growth begins. It can also be where cash flow gets tight.

You may be paying developers, engineers, scientists, technicians and suppliers months before receiving the benefit of an eligible R&D Tax Incentive claim. That timing gap can put pressure on working capital, particularly for growing companies that want to keep investing rather than waiting for the next tax refund.

An R&D tax prepayment loan agreement can potentially help bridge that gap.

Instead of waiting until an anticipated R&D tax benefit is received, an eligible business may be able to access funding earlier, subject to assessment, approval and the terms of the relevant loan agreement.

But what exactly are you signing? How does an R&D tax prepayment loan work? And what should you understand before entering into an agreement?

Here’s a practical guide.

What Is an R&D Tax Prepayment Loan?

An R&D tax prepayment loan is a form of business finance connected to an anticipated R&D Tax Incentive benefit.

Australia's R&D Tax Incentive is designed to encourage companies to undertake eligible research and development by offsetting some of the costs involved. The program is jointly administered by the Department of Industry, Science and Resources and the Australian Taxation Office.

For companies with aggregated turnover below $20 million, the refundable R&D tax offset is generally calculated as the company's corporate tax rate plus an 18.5% premium, subject to eligibility and applicable rules. Larger eligible businesses generally access a non-refundable offset calculated under different rules.

The important point from a cash-flow perspective is timing.

A company can incur substantial eligible R&D costs throughout a financial year, while the resulting tax benefit is generally claimed later through the R&D registration and company tax-return process.

R&D tax prepayment finance is intended to bring forward access to part of that anticipated value.

What Is an R&D Tax Prepayment Loan Agreement?

The R&D tax prepayment loan agreement is the contract setting out the terms under which the lender provides the funding and the borrower is required to repay it.

It is important to understand that the funding is a loan . It isn't an early payment made by the Australian Taxation Office and isn't itself an R&D Tax Incentive refund.

The agreement will generally establish matters such as the approved facility amount, interest and fees, drawdown conditions, repayment obligations, security arrangements and what happens if circumstances change.

Because these are contractual obligations, businesses should understand the agreement and obtain appropriate professional advice where necessary before signing.

How R&D Capital Partners' Prepayment Process Works

At R&D Capital Partners , the funding process is structured around the company's R&D activities and eligible expenditure.

The process generally begins with development of an R&D project plan. That plan needs to be prepared with the requirements of the Australian R&D Tax Incentive program in mind.

The company's proposed R&D expenditure is then assessed before the business applies for funding.

R&D Capital Partners currently describes three types of R&D tax prepayment funding:

Prior-year expenditure: Eligible R&D companies may seek a prepayment against previous-year expenditure before completing annual R&D registration and lodging the company tax return.

Current-year expenditure: Eligible businesses may be able to draw funding against current-year R&D expenditure periodically, such as quarterly or half-yearly.

Longer-term R&D funding: Funding may also be available against a partially funded R&D plan and budget supported by a positive Advance Finding, subject to the applicable lending criteria and agreement.

This flexibility can be valuable because different R&D businesses experience different cash-flow cycles.

Why Would a Company Consider R&D Tax Prepayment Funding?

The central reason is usually straightforward: cash flow .

Imagine an innovative technology company investing heavily in a new platform. Every month it has salaries, software expenses, testing costs and other operating commitments.

Some of those costs may ultimately form part of an eligible R&D Tax Incentive claim, but the business still has to fund them today.

Waiting for the normal R&D registration and tax-return cycle can leave capital tied up for months.

Accessing a portion of an anticipated R&D benefit earlier may give a company additional working capital to continue its development program.

Depending on the business, that money might help fund additional R&D expenditure, maintain development momentum, pay employees and contractors, invest in equipment or simply reduce pressure on existing cash reserves.

The trade-off is that finance has a cost. Interest, establishment fees, security requirements and other obligations need to be considered against the benefit of accessing capital sooner.

How Much Can Potentially Be Borrowed?

The amount available will depend on the lender's assessment, anticipated R&D position and the terms of the facility.

R&D Capital Partners states that its facilities currently range from $50,000 to $3 million , based on up to 80% of the projected tax return amount.

That does not mean every applicant will qualify for a particular amount. Funding remains subject to assessment, due diligence, documentation and approval.

Businesses should therefore avoid treating a projected R&D claim as guaranteed cash.

The Australian R&D Tax Incentive operates on a self-assessment basis. Companies remain responsible for ensuring their entity, activities and expenditure satisfy the relevant requirements.

What Security Is Involved?

Security is one of the most important parts of any business loan agreement.

R&D Capital Partners describes its R&D tax prepayment funding as a secured loan and states that its security includes a first-ranked charge over the company registered on the Personal Property Securities Register (PPSR).

That makes the loan agreement something directors should review carefully rather than regarding it as simply an "advance" on a refund.

Before entering any secured funding arrangement, understand what assets or rights are subject to security, your ongoing obligations and the consequences of a default.

How Is the Loan Repaid?

Under the R&D Capital Partners process, repayment is generally connected with receipt of the relevant tax refund.

The stated process provides for the ATO refund to be paid into the nominated trust account, with the loan repaid and the remaining balance returned to the client. The borrower may also repay earlier where required or permitted under the applicable agreement.

Interest is generally payable during the period in which the loan remains outstanding.

The precise mechanics matter. Borrowers should understand when interest begins accruing, how it is calculated, what fees apply, when repayments are due and what happens if the anticipated refund is delayed or differs from the original projection.

What Happens If the R&D Tax Benefit Is Lower Than Expected?

This is an important question to ask before borrowing.

R&D Tax Incentive eligibility isn't established simply because a business believes it has undertaken innovative work.

Companies must satisfy the program requirements and self-assess their eligibility. Registration of activities also does not, by itself, guarantee that every activity or expenditure item will ultimately be accepted as eligible.

That creates a risk when finance is based on an anticipated R&D position.

Before signing an R&D tax prepayment loan agreement, businesses should understand their repayment obligations if their R&D tax benefit is delayed, reduced, adjusted or unavailable.

This is also one reason why good R&D documentation and professional assessment can be so important.

The Importance of R&D Records

Strong documentation isn't only helpful for financing. It is fundamental to participating in the R&D Tax Incentive.

Businesses should maintain contemporaneous records that demonstrate the nature of their R&D activities, the technical uncertainties being investigated, the systematic progression of work undertaken and the expenditure associated with eligible activities.

For a core R&D activity, the outcome must not be able to be known or determined in advance and the activity must be conducted for the purpose of generating new knowledge.

Simply spending money developing a new product doesn't automatically make the expenditure eligible R&D.

Maintaining appropriate records throughout the project can make both the R&D claim and a funding assessment considerably more straightforward.

What Should You Check Before Signing an R&D Tax Prepayment Loan Agreement?

Don't look only at the amount available.

Consider the total cost of borrowing, establishment fees, interest calculation, repayment timing, security requirements, conditions applying to each drawdown, default provisions and what happens if your expected R&D benefit changes.

You should also understand whether early repayment is permitted and whether additional costs apply.

Most importantly, make sure the assumptions underlying the proposed funding are realistic.

A larger facility isn't automatically better. The right amount of funding depends on the company's actual cash-flow requirements, R&D expenditure and ability to meet its obligations.

Frequently Asked Questions

Is an R&D tax prepayment the same as an ATO refund?

No. An R&D tax prepayment loan is private financing. It provides eligible borrowers with earlier access to capital based on an anticipated R&D tax position, subject to the lender's requirements. It isn't an early refund issued by the ATO.

Do I have to repay an R&D tax prepayment loan?

Yes. It is a loan and is subject to the repayment obligations contained in the loan agreement.

Can I borrow against current-year R&D expenditure?

Potentially. R&D Capital Partners offers a current-year expenditure option that can allow eligible companies to draw funding against qualifying expenditure during the year, subject to assessment and approval.

Can I obtain funding for R&D expenditure from the previous financial year?

Potentially. R&D Capital Partners also provides a prior-year expenditure option for eligible R&D businesses, subject to its lending criteria and documentation.

How quickly can an R&D prepayment loan be approved?

R&D Capital Partners states that its due-diligence process is typically completed within 72 hours. Actual timing will depend on the circumstances of the application and whether the required information is available.

How quickly can funds be drawn after approval?

R&D Capital Partners states that following loan approval, funds can generally be available within two days of a drawdown notice confirming that eligible expenditure has been incurred, subject to the loan terms.

Is security required?

R&D Capital Partners describes its prepayment facility as a secured loan, including a first-ranked charge over the company registered on the PPSR.

Does receiving an R&D prepayment guarantee my R&D Tax Incentive claim?

No. Funding approval and R&D Tax Incentive eligibility are separate matters. Businesses remain responsible for satisfying the requirements of the R&D Tax Incentive program.

What is an Advance Finding?

An Advance Finding is a legally binding decision by the Department of Industry, Science and Resources concerning whether specified R&D activities are eligible. A positive Advance Finding can provide assurance about activity eligibility for up to three years, although it does not determine the eligibility of expenditure.

Is R&D tax prepayment finance right for every business?

No. Whether it makes commercial sense depends on factors including the company's expected R&D benefit, cash-flow needs, borrowing costs, security position and ability to repay. Appropriate financial, tax and legal advice should be considered where required.

Turning Future R&D Benefits Into Today's Working Capital

Innovation rarely happens according to the tax calendar.

Businesses need to pay researchers, developers, engineers and suppliers while the work is being done. For eligible Australian R&D companies, an R&D tax prepayment facility can potentially reduce the gap between spending money on innovation and receiving the associated tax benefit.

The key is understanding what you're entering into.

An R&D tax prepayment loan agreement is a commercial finance agreement with real costs, security arrangements and repayment obligations. When structured appropriately, however, bringing forward part of an anticipated R&D tax benefit can provide additional working capital at a time when an innovative business may need it most.

Businesses considering this type of funding can speak with R&D Capital Partners about available R&D tax prepayment options and the application process.

This article provides general information only and should not be regarded as legal, taxation or financial advice. Eligibility for the R&D Tax Incentive and any finance facility depends on individual circumstances.

What Is R&D Tax Incentive Prepayment Funding and How Does It Work?

Thu, 17 Sep 2026 05:35:44 GMT

What Is R&D Tax Incentive Prepayment Funding and How Does It Work?

For innovative Australian businesses, research and development can require substantial investment long before a new product, technology or process begins generating revenue. Salaries, prototypes, testing, software development and other R&D costs need to be paid as they arise, while the financial benefit available through the Australian Government’s R&D Tax Incentive generally comes later.

This timing difference can put pressure on cash flow, particularly for very early-stage and rapidly growing companies.

R&D Tax Incentive prepayment funding is designed to help bridge that gap. Rather than waiting until an eligible R&D Tax Incentive benefit is ultimately received through the tax system, qualifying companies may be able to obtain funding secured against their projected benefit.

R&D Capital Partners (R&DCP) provides specialist prepayment funding that allows Australian businesses undertaking eligible R&D to potentially access capital significantly earlier. R&DCP states that its funding can enable companies to use their projected R&D Tax Incentive benefit as security for funding up to a year before that benefit can otherwise be claimed.

Here is how the process works, who may qualify and what businesses should understand about applications, drawdowns and repayment.

What Is the R&D Tax Incentive?

The Australian Government’s Research and Development Tax Incentive (R&DTI) is designed to encourage companies to undertake eligible research and development by providing a tax offset for qualifying R&D expenditure.

For companies with aggregated turnover below $20 million, the refundable R&D tax offset is generally calculated as the company’s corporate tax rate plus an 18.5% premium. Different rules apply to companies with aggregated turnover of $20 million or more.

Eligibility depends on several factors, including the entity conducting the R&D, the nature of the activities and the expenditure being claimed.

For a core R&D activity, the activity must be undertaken to generate new knowledge, its outcome cannot be known or determined in advance, and that outcome must be determined through a systematic progression of work.

Businesses generally also need at least $20,000 in eligible R&D expenditure for the income year, although exceptions apply, including certain expenditure involving registered Research Service Providers and Cooperative Research Centre contributions.

The Cash Flow Challenge with the R&D Tax Incentive

The R&D Tax Incentive can provide valuable financial support, but there is an unavoidable timing issue.

A business incurs R&D expenditure throughout its financial year. It then needs to register its eligible R&D activities and claim the relevant tax offset through its company income tax return.

R&D Tax Incentive applications generally need to be submitted within 10 months after the end of the income year in which the R&D activities occurred.

Consequently, a significant period can exist between spending money on R&D and receiving the associated refundable tax offset.

That delay matters when a business is investing heavily in development.

A company may need cash today to employ engineers, scientists or developers, purchase materials, undertake testing or continue product development. Waiting for a future tax refund can potentially slow the R&D program or create the need to raise other forms of capital.

This is where R&D Tax Incentive prepayment funding can help.

What Is R&D Tax Incentive Prepayment Funding?

R&D Tax Incentive prepayment funding is a form of specialist finance in which a business obtains a loan based on its projected R&D Tax Incentive benefit.

Instead of waiting for the normal tax return and refund process, an eligible business can potentially bring forward a portion of the expected benefit and use the funds to support its operations and R&D program.

R&D Capital Partners focuses on the projected tax benefit as collateral rather than relying solely on the types of tangible security traditionally required by banks.

This can be particularly relevant to R&D-intensive businesses whose principal assets may be intellectual property, software, specialised knowledge or technology rather than property, plant and equipment.

R&DCP currently offers funding of between $50,000 and $3 million, based on up to 80% of the projected tax return, subject to its lending criteria, due diligence and loan terms.

Who May Be Eligible for R&D Tax Incentive Prepayment Funding?

Eligibility for financing and eligibility for the government R&D Tax Incentive are separate considerations.

At the government program level, an eligible R&D entity generally needs to be a corporation incorporated under Australian law, or meet specified requirements applying to certain foreign-incorporated companies.

The business must also undertake eligible R&D activities and incur eligible expenditure.

For R&D Capital Partners’ funding, a critical lending consideration is the eligibility of the underlying R&D expenditure.

Because the projected R&D Tax Incentive benefit supports the financing, R&DCP needs confidence that the activities and expenditure on which the projected benefit is based can qualify.

This makes accurate R&D planning and documentation particularly important.

How Does the Application Process Work?

R&D Capital Partners outlines a structured prepayment process.

First, the company develops an R&D project plan. The plan should identify the relevant R&D activities and associated expenditure and be prepared consistently with the requirements of the R&D Tax Incentive program.

The plan is then reviewed to assess the eligibility of the proposed R&D expenditure.

Once that foundation has been established, the company can apply to R&D Capital Partners for funding through its standard application process.

R&DCP then conducts its due diligence. The company states that this process is typically completed within 72 hours.

If the application is approved, the borrower signs the R&D Tax Prepayment Loan Agreement and pays the applicable establishment fee.

Funding can then be accessed in accordance with the agreed facility and as eligible expenditure is incurred.

How Do Drawdowns Work?

One important feature of R&D Tax Incentive prepayment funding is that businesses may not need to borrow the entire facility at once.

R&D Capital Partners states that an approved loan can be drawn down as expenditure under the R&D plan is incurred.

Following loan approval, funding is generally available within two days of a drawdown notice confirming that eligible expenditure has been incurred.

Drawdowns may occur on a monthly or quarterly basis, depending on the arrangement.

This approach can align funding more closely with the actual R&D expenditure cycle.

R&DCP describes three prepayment structures:

Prior-year expenditure: Funding may be provided against eligible expenditure already incurred in the previous year, before the company completes registration of its annual activities and lodges its company tax return.

Current-year expenditure: Eligible businesses may draw down funding against current-year R&D expenditure on a quarterly or half-yearly basis.

Longer-term R&D plans: Funding may also be structured around a partially funded R&D plan and budget supported by a positive Advance Finding, potentially allowing a prepayment loan to be provided at the beginning of a project or financial year.

An Advance Finding is a legally binding determination from the Department of Industry, Science and Resources concerning the eligibility of specified R&D activities.

It is optional for ordinary R&DTI claims but can provide greater certainty about activity eligibility.

How Is R&D Prepayment Funding Repaid?

The repayment structure is closely connected to the eventual R&D Tax Incentive refund.

Under R&DCP’s published process, monthly interest payments are made on each loan.

When the Australian Taxation Office pays the relevant tax refund, the refund is directed into R&DCP’s trust account.

The loan principal is then repaid from the tax refund, with any remaining balance returned to the client.

Borrowers may also repay the principal earlier if required.

This creates a relatively straightforward funding cycle:

Eligible R&D expenditure → prepayment funding → continued R&D activity → R&DTI registration and tax claim → ATO refund → loan repayment.

The precise costs, security requirements and repayment obligations will depend on the applicable loan agreement.

Why Would a Business Use R&D Tax Incentive Prepayment Funding?

The main advantage is timing.

Receiving capital earlier can allow an R&D-focused company to reinvest funds into its development program instead of waiting for a future tax refund.

For example, earlier access to funding could help a business continue employing technical staff, purchase materials, undertake additional experiments or testing, accelerate development milestones or simply extend its available cash runway.

Another potential advantage is avoiding immediate equity dilution.

Raising equity requires a company to issue ownership interests to investors. R&D prepayment funding is debt rather than equity, so obtaining the loan itself does not require issuing new shares.

That distinction can be valuable for founders and existing shareholders who want to finance continued development without undertaking another equity round at that particular stage.

Of course, debt funding has its own costs and obligations, including interest, fees, security and repayment requirements.

Businesses should therefore consider whether the facility suits their cash flow position and broader funding strategy.

Why R&D Documentation Matters

Businesses considering prepayment funding should not treat R&D Tax Incentive eligibility as automatic.

The R&DTI operates on a self-assessment basis. Companies are responsible for determining whether their entity, activities and expenditure satisfy the applicable requirements.

Registration of activities also does not, by itself, guarantee that those activities are eligible.

Government agencies can review R&D activities and expenditure.

Maintaining appropriate records throughout the R&D process is therefore important both for the eventual tax claim and for supporting a financing application.

Businesses should be able to demonstrate what technological or scientific uncertainty they were addressing, what new knowledge they sought to generate, what experiments or systematic work were undertaken, what outcomes were observed and which expenditure relates to eligible activities.

Turning a Future Tax Benefit into Capital Today

The R&D Tax Incentive is intended to encourage Australian companies to invest in innovation, but businesses still need to finance their R&D activities while the work is taking place.

R&D Tax Incentive prepayment funding provides a way for qualifying businesses to bridge the timing gap between incurring eligible expenditure and ultimately receiving their R&D Tax Incentive benefit.

By using a projected R&D tax benefit to support a specialist loan, a business may be able to access part of that value earlier, draw funds as qualifying expenditure is incurred and repay the facility when the corresponding tax refund is received.

For R&D-intensive companies, that can mean additional working capital at the point in the development cycle when it may be most useful.

R&D Capital Partners specialises in providing R&D Tax Incentive prepayment funding to Australian companies, with facilities structured around prior-year expenditure, current-year expenditure and, in appropriate circumstances, longer-term R&D programs.

Businesses considering prepayment funding should assess both their R&D Tax Incentive eligibility and the commercial terms of the proposed financing before proceeding.